Black Diamond Therapeutics, Inc. Stock
Stocks
BDTX
US09203E1055
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.970 USD | -1.99% |
|
+12.57% | -18.93% |
| 06-30 | Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) added to Russell 2000 Index | CI |
| 06-29 | Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) added to Russell 2000 Value Benchmark | CI |
| Market Cap | 113M 98.86M 91.06M 84.52M 161M 10.77B 163M 1.09B 424M 5.29B 424M 415M 18.33B | P/E 2026 * |
-3.04x | P/E 2027 * | -1.96x |
|---|---|---|---|---|---|
| Enterprise Value | 113M 98.86M 91.06M 84.52M 161M 10.77B 163M 1.09B 424M 5.29B 424M 415M 18.33B | EV / Sales 2026 * |
20.3x | EV / Sales 2027 * | - |
| Free-Float |
99.35% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -1.99% | ||
| 1 week | +12.57% | ||
| Current month | +6.49% | ||
| 3 months | -21.20% | ||
| 6 months | -24.23% | ||
| Current year | -18.93% |
| 1 week | 1.83 |  | 2.07 |
| 1 month | 1.6 | | 2.07 |
| Current year | 1.6 | | 3.97 |
| 1 year | 1.6 | | 4.94 |
| 3 years | 1.2 | | 7.66 |
| 5 years | 1.18 | | 12 |
| 10 years | 1.18 | | 46.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Velleca
CEO | Chief Executive Officer | 62 | 16/09/2023 |
Elizabeth Buck
CTO | Chief Tech/Sci/R&D Officer | 51 | 11/08/2021 |
Erika Jones
DFI | Director of Finance/CFO | 41 | 07/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Garry Menzel
BRD | Director/Board Member | 61 | 01/03/2017 |
Samarth Kulkarni
BRD | Director/Board Member | 47 | 01/12/2019 |
Ali Behbahani
BRD | Director/Board Member | 50 | 01/12/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-26 | Free | Director | 40,000 | 0.0698% | ||
| 06-26 | Free | Director | 40,000 | 0.0698% | ||
| 06-26 | Free | Director | 40,000 | 0.0698% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.99% | +12.57% | -23.64% | -56.03% | 113M | |
| -0.34% | -0.15% | +73.90% | +132.68% | 57.73B | |
| -0.93% | -2.54% | +73.64% | +93.71% | 54.69B | |
| -3.71% | -0.35% | -14.61% | -11.19% | 23.75B | |
| -0.05% | +6.49% | +14.05% | +451.36% | 24.18B | |
| -2.70% | +6.30% | +46.83% | -2.70% | 19.82B | |
| +2.42% | +4.37% | +43.23% | -27.13% | 17.14B | |
| +3.58% | +13.78% | +196.41% | +348.55% | 16.75B | |
| -1.81% | +17.84% | +45.86% | - | 15.57B | |
| -0.57% | +2.30% | +20.33% | +187.27% | 13.96B | |
| Average | -0.61% | +6.48% | +47.60% | +124.06% | 24.37B | |
| Weighted average by Cap. | -0.61% | +4.16% | +58.44% | +137.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.56M 4.87M 4.48M 4.16M 7.9M 530M 8.01M 53.64M 20.88M 260M 20.86M 20.41M 902M | - |
| Net income | -40.47M -35.45M -32.65M -30.3M -57.55M -3.86B -58.33M -391M -152M -1.9B -152M -149M -6.57B | -70.04M -61.35M -56.5M -52.45M -99.59M -6.68B -101M -676M -263M -3.28B -263M -257M -11.37B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/07/26 | US$1.970 | -1.99% | 1,789,748 |
| 02/07/26 | US$2.010 | +9.24% | 1,577,070 |
| 01/07/26 | US$1.840 | -0.54% | 4,375,137 |
| 30/06/26 | US$1.850 | +5.71% | 1,883,436 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BDTX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
